PHOENIX - s4story -- Dr. Richard Harding attended the 2026 annual North American Society for Interventional Thyroidology (NASIT) Conference in Portland, Oregon March 6-7, joining cutting‑edge world experts dedicated to advancing nonsurgical treatments for thyroid and endocrine disorders. The annual meeting brought together leaders from across the globe to share innovations, refine techniques, and strengthen the rapidly growing field of interventional endocrinology.

This year's conference featured keynote speaker Dr. Jung Hwan Baek, MD, PhD, internationally recognized as the pioneer of thyroid ablation. Dr. Baek, based in Seoul, South Korea, has spent 24 years developing and refining techniques for healing thyroid cancer and benign thyroid disease. As Chief of Research Affairs at Asan Medical Center and President of the Korean Society of Thyroid Radiology, he has led clinical trials and introduced advanced diagnostic and interventional procedures including core needle biopsy, ethanol ablation (EA), radiofrequency ablation (RFA), and artificial‑intelligence–driven thyroid CAD systems such as S‑Detect for Thyroid.

More on S For Story

• RecallSentry™ App Launch — Your Home Safety Hub — Free on iOS & Android
• Award-Winning Director Crystal J. Huang's Under-$50K Film "The Ritual House" Wins Best Horror Feature at Golden State Film Festival
• Grads aren't getting hired — here's what we're doing about it
• K2 Integrity Enhances Technology Capabilities Through Acquisition of Leviathan Security Group
• #WeAreGreekWarriors Comes to Detroit in Celebration of Women's History Month

https://www.youtube.com/shorts/dXAY3O6jjfA

"Learning directly from pioneers like Dr. Baek reinforces why interventional thyroidology is transforming patient care. His decades of innovation continue to push the field forward, and I'm committed to bringing these least‑invasive, evidence‑based techniques to the patients I serve. Our goal is always the same — effective treatment with the smallest possible impact on a patient's life," said Dr. Harding.

Dr. Harding's participation in the 2026 NASIT Conference underscores his commitment to bringing the latest, least‑invasive treatment options to patients in the United States. By engaging directly with global leaders such as Dr. Baek, Dr. Harding continues to advance his practice's mission of offering safe, effective alternatives to conventional thyroid surgery.

Richard J. Harding, MD, FACS, is a board certified General Surgeon specializing in minimally invasive and endocrine surgery. For more than 30 years, he has focused on advanced, small‑incision techniques that reduce pain, shorten recovery, and preserve normal function. Dr. Harding offers comprehensive diagnostic evaluation and a full range of surgical and nonsurgical options at Arizona Endocrine Surgery and Thyroid Nodule Treatment Center. https://azthyroidnodule.com

More on S For Story

• Energywise Solutions and Pickleball Pros Partner to Bring More Energy and Visibility to Pickleball Clubs
• Buildout Launches CRM, Completing the Industry's First AI-Powered End-to-End Deal Engine for CRE
• The Franchise King® Releases Free Guide for Nervous Buyers
• Kanguro Insurance Taps Paylode to Launch Best-in-Class Pet and Renters Insurance Rewards Experience
• CCHR: CIA Mind-Control Files Raise Urgent Questions as Millions Take Psychotropic Drugs

About NASIT
NASIT is a multidisciplinary professional society composed of surgeons, medical endocrinologists, radiologists, and pathologists who perform thyroid ablation procedures, including Radiofrequency Ablation (RFA). The society's mission is to advance safe, effective, minimally invasive alternatives to traditional thyroid surgery through research, education, and clinical collaboration. https://nasit.org